Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Strong Long	4/19/2016 11:50:04 AM
	Read Replies (1) of 2026

PR it certainly does make sense that it could be Forendo getting out, and I certainly understand your frustration with Pascoe. Obviously, his track record with Apricus does not scream winner and it is possible that APRI stock is so toxic now, that the market may never value it in a meaningful way. That said, there has been some execution on Pascoe's watch, and I have to believe that a company with a marketed ED drug is worth more than $0.60 a share. I agree with James, Pascoe should be held to account, and I too would like to see pay cuts and bonuses reduced/frozen until profitability. I am still willing to bet my shares that APRI can do better than the current pps...holding for another year should be all it takes to determine if that is the case. My eyes were wide open going into this investment, and I will ride it out for better or worse...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next